Meristem Therapeutics

A biotechnology company and a leader in the production of therapeutic recombinant proteins, in plants, for the pharmaceutical industry.
MERISTEM® THERAPEUTICS has developed a technological platform able to ensure the production of recombinant proteins from the gene up to production of several tons of purified active substances. The platform is particularly suitable for the large-scale, cost-effective production of antibodies. The Molecular Pharming® plant engineering program constitutes a major breakthrough compared to existing processes.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Generics
- Phyto
- Proteins
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter: France

b. Continent(s) active: Europe , North America

c. Countries active: The company also has subsidiaries in Burgundy, France, and Florida, USA

Corporate data:

Number of Employees: 85

Turnover:

Amount:	Year:	Currency:

Year founded: 1997